SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-000389
Filing Date
2018-01-24
Accepted
2018-01-24 16:02:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2234353z424b5.htm 424B5 391178
2 G124138.JPG g124138.jpg GRAPHIC 14802
  Complete submission text file 0001047469-18-000389.txt   412650
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219794 | Film No.: 18545182
SIC: 2834 Pharmaceutical Preparations